Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sugammadex ED90 Dose to Reverse the Rocuronium Blockade in the Obese Patients

NCT02568345 is registered in ClinicalTrials.gov with Faculdade de Ciências Médicas da Santa Casa de São Paulo as lead sponsor.

NCT NCT02568345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02568345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sugammadex ED90 Dose to Reverse the Rocuronium Blockade in the Obese Patients
Lead sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
January 31, 2014
Enrollment
31 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

incomplete reversal of neuromuscular block